Friday, December 02, 2016 3:48:05 PM
With the encouragement of the research community and the pharmaceutical industry, both sought legislation that would make it easier to find life-saving cures by cutting barriers that hold up clinical trials and the approval of new drugs and devices those studies can lead to.
“Those changes will last for decades after the money is spent,” DeGette said in an interview. “It’s really not just bringing devices and drugs to market more quickly, but it’s also being able to expedite the basic research behind the way we’re developing these devices.”
The White House gave the final compromise its strong support, saying the legislation “offers advances in health that far outweigh” its concerns about the funding of the bill, which came partly from selling off oil from the Strategic Petroleum Reserve.
www.theatlantic.com/politics/archive/2016/12/cures-act-compromise-elizabeth-warren/509228/
The 21st Century Cures Act will be a done deal come next week. I emailed management (Nov 30) for a response to new legislation, and it's potential impact on clinical trials and costs moving forward. I encourage others to do so as well. Meanwhile, I'm looking forward to the Monthly Report (Dec 5 2016).
T.G.I.F.
/////AMG
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM